| Autor: |
Lorentzos, Michelle S, Metz, David, Moore, Andrew S, Fawcett, Laura K, Bray, Paula, Attwood, Lani, Munns, Craig F, Davidson, Andrew |
| Zdroj: |
Medical Journal of Australia; 2/19/2024, Vol. 220 Issue 3, p121-125, 5p |
| Abstrakt: |
This article discusses the importance of increasing access to new therapies for Australian children and adolescents through clinical trials. It emphasizes the need for investment and a coordinated national approach to ensure that Australian children do not fall behind their international peers. The article highlights the benefits of collaborative approaches and strategic investment in pediatric clinical trials, as well as the challenges in delivering high-quality trials in this population. It acknowledges the additional challenges faced in Australia due to distance and regulatory factors, and calls for equitable access to emerging treatments for all Australian children, regardless of their circumstances. The article concludes by emphasizing the need for national investment in pediatric clinical trial delivery in Australia. [Extracted from the article] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text